Numinus Wellness Inc. Blog | Talkmarkets | Page 1
No data available
No data available

Latest Posts

About This Stock More About This Stock
3 Of 5 Cannabis Categories Declined During Third Week Of May
Article By: Lorimer Wilson
Sunday, May 22, 2022 8:53 PM EDT
The cannabis sector consists of 5 distinct categories and they each performed quite differently from each other during the third week of May.
In this article: CGC, ZYNE, IIPR, CRON, TLRY, TCNNF, OGI, FORA, GDNSF, NUMIF
Read
S 2 Of The 5 Cannabis Categories Advance Slightly
Article By: Lorimer Wilson
Saturday, May 14, 2022 9:26 PM EDT
During the second week of May, two of the 5 categories we index showed some improvement; here, the numbers for all the stocks in all 5 categories for last week, YTD and from the 2021 peak.
In this article: SMG, CGC, MNMD, ZYNE, CURLF, TCNNF, OGI, FORA, GDNSF, GHRS, CYBN, NUMIF
Read
S Psychedelic Compounds-Based Drug Stocks Down Slightly This Past Week
Article By: Lorimer Wilson
Sunday, March 27, 2022 9:40 AM EDT
We're tracking 13 public companies (US and/or Canada) doing clinical-stage research into THC and/or psychedelics for treating mental illnesses. While a few were up this week, the overall trend continues downward.
In this article: MNMD, GHRS, NUMIF
Read
S Psychedelic Stocks Finally In An Upswing
Article By: Lorimer Wilson
Sunday, February 6, 2022 8:12 PM EDT
The Marijuana & Psychedelic Compounds-Based Drug Stocks Index went up +5.3% last week.
In this article: ATAI, MNMD, ZYNE, GHRS, DMTTF, CYBN, FTRP, NUMIF
Read
S The Psychedelic & Marijuana Drug Stocks Index Dropped -30% In January
Article By: Lorimer Wilson
Sunday, January 30, 2022 11:50 AM EDT
This article updates the performances of 16 clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses.
In this article: ATAI, MNMD, CMPS, ZYNE, CRBP, SEEL, GHRS, ALID, CYBN, FTRP, AWKNF, NUMIF
Read

Latest Tweets for $NUMIF

No tweets yet!

PARTNER HEADLINES